Savvy Updates 6/19/23: DIY vs. Commercial Closed-Loop Systems, Dexcom Private Deals w/ PBMs and How Senseonics Finds a Loophole, FDA’s Tap Program, Scoparia Dulcis & Retinopathy, Stress & Comfort Food, Which Sense Evolved First?, Doctors & “Moral Injury”
Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes, an upcoming presentation by Dana M. Lewis, developer of OpenAPS, to the American Diabetes Association 83rd Scientific Sessions, 23 June 2023. What is your presentation about? This...
Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?
Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M by Elise Reuter for MedTechDive.com, 5 June 2023. Novo Nordisk wants to innovate faster and develop new connected devices, and expects that Biocorp would complement its internal efforts, said...
Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth
Know Labs reports data from feasibility study of Bio-RFID sensor reported on MedicalDevice-Network.com, 8 May 2023. Know Labs has reported data from a new technical feasibility study of its Bio-RFID sensor technology for non-invasive glucose monitoring, compared to...
Savvy Updates, 5/8/23: CGM Disruptions (Dexcom & Abbott), Japanese Diet & NAFLD, UPFs & Brain Health, Weight Loss Drug $$, Envision Bankruptcy
Most adults with diabetes report CGM disruptions due to device problems, medical care by Alexis McKee for Healio.com/endocrinology, 3 May 2024. More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of...
Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023
Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
More Diabetes Blogs